share_log

Shareholders in Huafon Chemical (SZSE:002064) Are in the Red If They Invested Three Years Ago

Shareholders in Huafon Chemical (SZSE:002064) Are in the Red If They Invested Three Years Ago

華豐化學(SZSE:002064)的股東如果在三年前進行投資,則處於虧損狀態
Simply Wall St ·  03/05 22:00

Huafon Chemical Co., Ltd. (SZSE:002064) shareholders should be happy to see the share price up 16% in the last month. But that cannot eclipse the less-than-impressive returns over the last three years. After all, the share price is down 47% in the last three years, significantly under-performing the market.

華豐化工有限公司(深圳證券交易所:002064)股東應該很高興看到上個月股價上漲了16%。但這並不能掩蓋過去三年來不那麼令人印象深刻的回報。畢竟,股價在過去三年中下跌了47%,表現大大低於市場。

So let's have a look and see if the longer term performance of the company has been in line with the underlying business' progress.

因此,讓我們來看看公司的長期表現是否與基礎業務的進展一致。

While markets are a powerful pricing mechanism, share prices reflect investor sentiment, not just underlying business performance. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price.

雖然市場是一種強大的定價機制,但股價反映了投資者的情緒,而不僅僅是潛在的業務表現。評估公司情緒變化的一種有缺陷但合理的方法是將每股收益(EPS)與股價進行比較。

During the unfortunate three years of share price decline, Huafon Chemical actually saw its earnings per share (EPS) improve by 7.1% per year. This is quite a puzzle, and suggests there might be something temporarily buoying the share price. Or else the company was over-hyped in the past, and so its growth has disappointed.

在不幸的三年股價下跌中,華豐化學的每股收益(EPS)實際上每年增長7.1%。這真是個難題,表明股價可能會暫時上漲。否則,該公司過去曾被過度炒作,因此其增長令人失望。

Since the change in EPS doesn't seem to correlate with the change in share price, it's worth taking a look at other metrics.

由於每股收益的變化似乎與股價的變化無關,因此值得一看其他指標。

We note that, in three years, revenue has actually grown at a 15% annual rate, so that doesn't seem to be a reason to sell shares. It's probably worth investigating Huafon Chemical further; while we may be missing something on this analysis, there might also be an opportunity.

我們注意到,在三年內,收入實際上以15%的年增長率增長,因此這似乎不是出售股票的理由。可能值得進一步研究華豐化學;雖然我們在分析中可能遺漏了一些東西,但也可能有機會。

You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values).

您可以在下圖中看到收入和收入隨時間推移而發生的變化(點擊圖表查看確切值)。

earnings-and-revenue-growth
SZSE:002064 Earnings and Revenue Growth March 6th 2024
SZSE: 002064 收益和收入增長 2024 年 3 月 6 日

Balance sheet strength is crucial. It might be well worthwhile taking a look at our free report on how its financial position has changed over time.

資產負債表的強度至關重要。可能值得一看我們關於其財務狀況如何隨着時間的推移而變化的免費報告。

What About Dividends?

分紅呢?

When looking at investment returns, it is important to consider the difference between total shareholder return (TSR) and share price return. The TSR is a return calculation that accounts for the value of cash dividends (assuming that any dividend received was reinvested) and the calculated value of any discounted capital raisings and spin-offs. It's fair to say that the TSR gives a more complete picture for stocks that pay a dividend. In the case of Huafon Chemical, it has a TSR of -43% for the last 3 years. That exceeds its share price return that we previously mentioned. This is largely a result of its dividend payments!

在考慮投資回報時,重要的是要考慮兩者之間的區別 股東總回報 (TSR) 和 股價回報。股東總回報率是一種回報計算方法,它考慮了現金分紅的價值(假設收到的任何股息都經過再投資)以及任何貼現資本籌集和分拆的計算價值。可以公平地說,股東總回報率爲支付股息的股票提供了更完整的畫面。以華豐化學爲例,在過去三年中,其股東回報率爲-43%。這超過了我們之前提到的其股價回報率。這在很大程度上是其股息支付的結果!

A Different Perspective

不同的視角

Although it hurts that Huafon Chemical returned a loss of 7.7% in the last twelve months, the broader market was actually worse, returning a loss of 16%. Of course, the long term returns are far more important and the good news is that over five years, the stock has returned 6% for each year. It could be that the business is just facing some short term problems, but shareholders should keep a close eye on the fundamentals. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. To that end, you should learn about the 3 warning signs we've spotted with Huafon Chemical (including 1 which is a bit unpleasant) .

儘管華豐化學在過去十二個月中回報了7.7%的虧損令人痛心,但整個市場實際上更糟,虧損了16%。當然,長期回報要重要得多,好消息是,在過去的五年中,該股每年的回報率爲6%。可能是該企業正面臨一些短期問題,但股東應密切關注基本面。儘管市場狀況可能對股價產生的不同影響值得考慮,但還有其他因素更爲重要。爲此,你應該了解我們在華豐化學身上發現的3個警告信號(包括一個有點不愉快的警示信號)。

Of course Huafon Chemical may not be the best stock to buy. So you may wish to see this free collection of growth stocks.

當然,華豐化工可能不是最好的買入股票。因此,您可能希望看到這批免費的成長股。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

請注意,本文引用的市場回報反映了目前在中國交易所交易的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論